STOCK TITAN

Medwellai (MWAI) 8-K Filings

MWAI OTC

Here are the 8-K filings from Medwellai Inc (MWAI) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

An 8-K covers material events a company has to report between its quarterly reports, so if you follow MWAI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MWAI filings page.

Rhea-AI Summary

MedWellAI, Inc. changed the terms of its preferred stock by amending the Certificate of Designation for its Series B Convertible Preferred Stock. On April 16, 2026, the company filed a Certificate of Amendment in Nevada increasing the designated and authorized Series B Convertible Preferred shares from 1,000,000 to 1,500,000.

All other rights and preferences of the Series B Convertible Preferred Stock remain governed by the existing Certificate of Designation, which stays in full force and effect except for this share increase.